Press release
Urinary Incontinence Treatment Devices Market Forecast 2031: Growing Awareness and Demand for Non-invasive Solutions Fuel Expansion | Transparency Market Research, Inc
Urinary Incontinence Treatment Devices Market
Preview crucial insights and findings from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=26612
Technological advancements, particularly in non-invasive electrical stimulation devices, are reshaping treatment options, offering effective and safe solutions for various types of urinary incontinence. Favorable reimbursement policies and increased investments in research and development (R&D) by leading healthcare companies further propel the market.
Analysts' Viewpoint
The urinary incontinence treatment devices market is witnessing substantial growth, driven by a combination of medical advancements and increased disease awareness. More than 60% of women experience some form of urinary incontinence, fueling demand for wearable and non-implantable treatment solutions.
Companies are focusing on launching minimally invasive and over-the-counter (OTC) electrical stimulation devices. Medtronic's NURO System, which provides percutaneous tibial nerve stimulation (PTNS) for overactive bladder treatment, is a notable innovation in this space.
With a large, aging population and growing adoption of advanced medical technologies, the market is poised for sustained growth, particularly in North America and Europe.
Key Market Drivers
High Prevalence of Urinary Incontinence and Overactive Bladder
Urinary incontinence affects over 500 million people globally, with stress urinary incontinence (SUI) and urge urinary incontinence (UUI) being the most common forms.
The condition has significant physical, psychological, and emotional effects, increasing the need for effective treatment options.
Rising Incidence of Prostate Cancer Driving Demand for Treatment Devices
Prostate cancer is the second most common cancer in men, with many patients developing post-prostatectomy urinary incontinence.
Studies indicate that 2% to 69% of men experience stress urinary incontinence after undergoing prostate surgery, driving demand for artificial urinary sphincters and implantable electrical stimulation devices.
Shift Toward Non-Invasive and Minimally Invasive Treatment Options
Wearable and non-implantable electrical stimulation devices are gaining popularity due to higher success rates and minimal recovery time.
The U.S. and European healthcare systems support such devices through favorable reimbursement policies, further boosting adoption.
Visit our report to explore the detailed insights and key takeaways -
https://www.transparencymarketresearch.com/urinary-incontinence-treatment-devices-market.html
Market Segmentation
By Product Type
Urethral Slings
Female Slings, Male Slings
Electrical Stimulation Devices
Implantable, Non-implantable
Artificial Urinary Sphincters
Catheters
By Incontinence Type
Stress Urinary Incontinence, Urge Urinary Incontinence, Mixed Incontinence, Overflow Incontinence
By End-User
Hospitals, Ambulatory Surgery Centers, Clinics, Home Use
By Region
North America (Largest Market - 42% share in 2021)
Europe (32% market share in 2021)
Asia Pacific
Latin America
Middle East & Africa
Regional Outlook
North America (42% Market Share in 2021)
Early adoption of advanced technologies and a large patient pool contribute to market dominance.
Favorable reimbursement policies in the U.S. and Canada encourage adoption of urinary incontinence treatment devices.
Europe (32% Market Share in 2021)
High prevalence of urinary incontinence and strong presence of medical device companies drive market growth.
Government initiatives for women's health in countries like Germany and France support market expansion.
Asia Pacific (Fastest Growth Rate Expected)
Rising geriatric population, particularly in China and Japan, increases demand for urinary incontinence treatment devices.
Improving healthcare infrastructure and growing awareness about available treatment options fuel market expansion.
Latin America and Middle East & Africa (MEA)
Latin America is expected to grow faster than MEA due to increased access to healthcare solutions and expansion of medical device companies in the region.
Competitive Landscape
The global urinary incontinence treatment devices market is characterized by intense competition, with major players focusing on technological advancements, strategic collaborations, and product innovations.
Key Market Players
R. Bard, Inc. (Becton, Dickinson and Company)
Coloplast Group
Medtronic plc
Ethicon US, LLC (Johnson & Johnson)
Hollister Incorporated
Atlantic Therapeutics Group Ltd.
Braun Melsungen AG
Teleflex Incorporated
Want to know more? Get in touch now. -https://www.transparencymarketresearch.com/contact-us.html
Notable Market Developments
December 2021: Caldera Medical received FDA clearance for DESARA TVez, a device for treating female stress urinary incontinence.
May 2020: Rigicon launched ContiClassic and ContiReflex Artificial Urinary Sphincters, expanding treatment options for severe urinary incontinence cases.
Explore Latest Research Reports by Transparency Market Research:
Endoscopic Stricture Management Device Market - https://www.transparencymarketresearch.com/endoscopic-stricture-management-device-market.html
Flowable Hemostats Market - https://www.transparencymarketresearch.com/flowable-hemostats-market.html
Hormonal Contraceptive Market - https://www.transparencymarketresearch.com/hormonal-contraceptives-market.html
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Urinary Incontinence Treatment Devices Market Forecast 2031: Growing Awareness and Demand for Non-invasive Solutions Fuel Expansion | Transparency Market Research, Inc here
News-ID: 4064476 • Views: …
More Releases from Transparency Market Research
Tissue Sealants & Adhesives Market to Surpass USD 4.6 Bn by 2035 | Rising Demand …
The global Tissue Sealants & Adhesives Market, valued at US$ 2,302.9 Mn in 2024, is poised for substantial expansion, projected to reach over US$ 4,607.0 Mn by 2035, growing at a compound annual growth rate (CAGR) of 6.4% from 2025 to 2035. Transparency Market Research's latest analysis reveals that increasing adoption of bio-adhesives, heightened awareness of advanced wound care solutions, and a shift toward minimally invasive surgical procedures are the…
Respiratory Syncytial Virus Vaccine Market Forecast 2035: Rising Infant Immuniza …
The global Respiratory Syncytial Virus (RSV) vaccine market is entering a transformative era. With rising awareness of RSV's burden on public health especially among infants, the elderly, and immunocompromised individual's healthcare systems are urgently embracing innovative immunization strategies. According to Transparency Market Research, the global RSV vaccine market, which was valued at US$ 3.7 Bn in 2024, is projected to cross US$ 15.9 Bn by 2035, growing at an impressive…
Digital Pathology Market Forecast 2035: AI Integration and Demand for Remote Dia …
The global digital pathology market is witnessing rapid expansion, propelled by advancements in imaging technology, the adoption of artificial intelligence (AI), and a growing emphasis on diagnostic accuracy and workflow efficiency. From being a niche innovation to becoming an indispensable component of modern diagnostic workflows, digital pathology is revolutionizing how pathologists work. Valued at US$ 1.1 Bn in 2024, the market is forecast to grow at an impressive CAGR of…
Intrauterine Devices Market Forecast 2035: Growing Focus on Long-acting Contrace …
The global intrauterine devices (IUDs) market is on a robust growth trajectory. Valued at US$ 4.7 billion in 2024, it is forecast to expand at a healthy CAGR of 10.6% between 2025 and 2035, ultimately crossing US$ 14.2 billion by the end of 2035. This strong performance reflects the market's evolution as demand for safe, long-acting, and reversible contraceptives rises worldwide. Key factors such as increased awareness, supportive government initiatives,…
More Releases for Urinary
Urinary Incontinence - Drug Pipeline Landscape, 2022
Urinary incontinence (UI) is the involuntary leakage of urine. UI happens when the muscles in the bladder that control the flow of urine contract or relax involuntarily, resulting in leaks or uncontrolled urination.
The common causes of urinary incontinence include overactive bladder muscles, weakened pelvic floor muscles, nerve damage, interstitial cystitis (chronic bladder inflammation), obstruction, neurological disorders such as multiple sclerosis, stroke, or parkinson's disease. Urinary incontinence may also be caused…
Urinary Incontinence Market Growing by Digital Therapeutic Device Improves Urina …
Demand Analysis of Urinary Incontinence Market Overview:
The Urinary Incontinence Market is predicted to grow at a moderate CAGR of 8.42% during the forecast period covering 2020 to 2029. Urinary Incontinence Market share is estimated to reach a value of nearly US$ 6,718 million by 2029.
The "Urinary Incontinence Market" think about 2022, the industry landscape is secured from driving factors to upstream markets and the by and large state of the…
Urinary Incontinence Treatment Devices Market: High Prevalence of Urinary Incont …
The global urinary incontinence treatment devices market is driven by high prevalence and rapidly increasing incidence of urinary incontinence across the globe. The global market was valued at US$ 2.08 Bn in 2017 and is projected to expand at a CAGR of 7.4% from 2018 to 2026 to reach US$ 3.92 Bn by 2026. High growth of the market is attributed to increase in adoption, easy availability of electrical vaginal…
Urinary Incontinence - Pipeline Review, H1 2018
"The Report Urinary Incontinence - Pipeline Review, H1 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
About Urinary Incontinence Market
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Urinary Incontinence - Pipeline Review, H1 2018, provides an overview of the Urinary Incontinence (Genito Urinary System And Sex Hormones) pipeline landscape.
Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1509366
Urinary incontinence…
Increasing Number of Surgical Procedures and Urinary Incontinence is Likely to D …
Urinary catheter is flexible tube, generally made up of silicone, latex or polyurethane, inserted through the tube that carries urine to collect the urine in a drainage bag. Urinary catheters are inserted by doctors or nurses through small opening created to a lower abdomen. With increased stress at workplaces and busy lifestyles of the people worldwide, the number of health disorders such as bladder dysfunction, kidney failure, chronic diseases and…
Urinary Incontinence - Pipeline Review, H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Urinary Incontinence - Pipeline Review, H1 2017, provides an overview of the Urinary Incontinence (Genito Urinary System And Sex Hormones) pipeline landscape.
Urinary incontinence is a loss of control of the bladder. In some cases, it may result in a total loss of the bladder’s contents or it may just cause minor leakage. Symptoms include stress incontinence, rashes and other skin disorders. Risk…
